HIF1A and cancer: HIF-1α is a master regulator in angiogenesis, metabolic reprogramming, epithelial-mesenchymal transition, stem cell maintenance, invasion, metastasis and resistance to several therapies making it a major target for therapeutic development in cancer [18], [19], however development of small-molecule HIF-1α inhibitors has been a major challenge.